HTSR: Kallakury Principal Investigator: Weiner, Louis M. PROJECT SUMMARY (See instructions): Histopathology and Tissue Shared Resource - Bhaskar V.S. Kallakury MD The Histopathology and Tissue Shared Resource (HTSR) provides investigators with comprehensive, high quality histology and pathology services. The HTSR was established in 1991 and became a Cancer Center Support Grant (CCSG) shared resource in 1993. The HTSR is comprised of the Human Tissue Bank (HTB) and the Histology Laboratory that work together to provide an efficient, single location, comprehensive resource for Lombardi Comprehensive Cancer Center (Lombardi) investigators. The HTB collects and processes tissues for the Fresh Frozen Tissue Bank, maintains a searchable database of the frozen tissues with links to demographic and pathology data, provides clinical support for the collection, processing and embedding of patient tissues for designated projects, and provides database searches, pathology evaluation, and tissue block retrieval of archival paraffin embedded patient tumor and normal tissues obtained through procedures performed at Georgetown University Hospital. The Histology Laboratory provides a broad array of histological services including necropsy, processing and embedding of fresh tissue, microtomy, routine and special staining, immunohistochemistry, laser capture microdissection and tissue microarray. In addition, the HTSR provides expert technical support and consultation services as well as an array of imaging equipment to support publication quality imaging and automated data analysis. The HTSR director. Dr. Bhaskar V.S. Kallakury, is a board certified practicing pathologist who provides pathology services related to both human and animal tissues for investigators through HTSR. The HTB has consented 6,134 patients to date, providing access to all paraffin-embedded tissues from these patients, as well as providing matching fresh frozen tissues for 2,980 of these patients. A plan is under way to enhance a database of clinical follow up data on these patients as part of the Georgetown Database of Cancer (G-DOC) initiative. Confidentiality is maintained with all bio-specimens at the HTSR; all samples are completely anonymized before being given to the investigator. Five programs in the CCSG encompassing 43 peer-reviewed Lombardi investigators account for 83% usage of the HTSR. Since the last review (in 2002), the HTSR has increased its capacity through the purchase of additional microtomes, processing and embedding stations, and high throughput automated stainers both for routine staining and for immunohistochemistry. The use of the HTSR by Lombardi investigators and its productivity have both increased. Since 2002, the number of histology slides produced has almost doubled, the number of immunohistochemistry slides stained has increased over five fold, and chargebacks have tripled. With the expansion of the HTSR's capacity, its contribution to the Lombardi research program has risen considerably, making the HTSR an indispensable facility for the Lombardi research community.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA051008-18
Application #
8256576
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2011-05-01
Budget End
2012-04-30
Support Year
18
Fiscal Year
2011
Total Cost
$76,403
Indirect Cost
Name
Georgetown University
Department
Type
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Lee, Yichien; Rodriguez, Olga C; Albanese, Chris et al. (2018) Divergent brain changes in two audiogenic rat strains: A voxel-based morphometry and diffusion tensor imaging comparison of the genetically epilepsy prone rat (GEPR-3) and the Wistar Audiogenic Rat (WAR). Neurobiol Dis 111:80-90
Coia, Heidi; Ma, Ning; Hou, Yanqi et al. (2018) Prevention of Lipid Peroxidation-derived Cyclic DNA Adduct and Mutation in High-Fat Diet-induced Hepatocarcinogenesis by Theaphenon E. Cancer Prev Res (Phila) 11:665-676
Ory, Virginie; Kietzman, William B; Boeckelman, Jacob et al. (2018) The PPAR? agonist efatutazone delays invasive progression and induces differentiation of ductal carcinoma in situ. Breast Cancer Res Treat 169:47-57
Ozawa, Patricia Midori Murobushi; Alkhilaiwi, Faris; Cavalli, Iglenir João et al. (2018) Extracellular vesicles from triple-negative breast cancer cells promote proliferation and drug resistance in non-tumorigenic breast cells. Breast Cancer Res Treat 172:713-723
Smith, Jill P; Wang, Shangzi; Nadella, Sandeep et al. (2018) Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice. Cancer Immunol Immunother 67:195-207
Edwardson, Matthew A; Zhong, Xiaogang; Fiandaca, Massimo S et al. (2018) Plasma microRNA markers of upper limb recovery following human stroke. Sci Rep 8:12558
Kaat, Aaron J; Schalet, Benjamin D; Rutsohn, Joshua et al. (2018) Physical function metric over measure: An illustration with the Patient-Reported Outcomes Measurement Information System (PROMIS) and the Functional Assessment of Cancer Therapy (FACT). Cancer 124:153-160
Maximov, Philipp Y; Abderrahman, Balkees; Fanning, Sean W et al. (2018) Endoxifen, 4-Hydroxytamoxifen and an Estrogenic Derivative Modulate Estrogen Receptor Complex Mediated Apoptosis in Breast Cancer. Mol Pharmacol 94:812-822
Czarnecka, Magdalena; Lu, Congyi; Pons, Jennifer et al. (2018) Neuropeptide Y receptor interactions regulate its mitogenic activity. Neuropeptides :
Gonzalez, Thomas L; Moos, Rebecca K; Gersch, Christina L et al. (2018) Metabolites of n-Butylparaben and iso-Butylparaben Exhibit Estrogenic Properties in MCF-7 and T47D Human Breast Cancer Cell Lines. Toxicol Sci 164:50-59

Showing the most recent 10 out of 1120 publications